Press Release
Business Food and Beverages Health Industry News Science

Cinryze C1 Drug Insight, 2019

delveinsight

Cinryze Drug Insights, 2019” report by DelveInsight provides comprehensive information of the drug, Cinryze. It includes Cinryze`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Cinryze`s patents (US & EU). It also features the historical and forecasted sales of Cinryze till 2022. The report also throws light on Cinryze`s market competition and emerging therapies in the same space as Cinryze. A SWOT analysis of the drug is also featured.
* Depending on information availability

Overview of development activities around Cinryze
The segment comprises of detailed description of the product especially highlighting its regulatory milestones, research and development, deals & partnerships, patent and technology details.

Global Sales Assessment and analysis of market competition
Graphical representation of historical and forecasted global sales of Cinryze till 2022 and marked attention on the current market competition and upcoming emerging therapies in the same space.

Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report

• A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report

• Patent information around Cinryze in the United States (US) and Europe (EU) has been highlighted

• The report contains historical and forecasted sales for Cinryze till 2022

• Comprehensive coverage of the emerging therapies (Phase III) in the space where Cinryze operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information

• The report also features the SWOT analysis of Cinryze

Reasons to Buy

• Establish a comprehensive understanding of the drug, Cinryze

• Plan developmental timelines around Cinryze`s patents for the major markets- US and EU

• Understand Cinryze`s current and future growth through its historical and forecasted sales

• Identify and understand the current in-market competitors for Cinryze

• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine

• Identify and plan ahead for prospective emerging players and their products operating in the same space as Cinryze

• Identify opportunities in the same area as Cinryze with DelveInsight`s SWOT analysis

Request for sample pages

Table of contents

  1. Introduction
  2. Cinryze – Overview
  3. Product Description
  4. Dosage and Strengths
  5. Route of Synthesis
  6. Mechanism of Action
  7. Pharmacology
  8. Pharmacodynamics
  9. Pharmacokinetics
  10. Adverse Reactions
  11. Clinical Studies
  12. Adolescent & Adult Study Results
  13. Pediatric Study Results
  14. Other Pipeline Activity
  15. Regulatory Milestones
  16. European Market Approval
  17. United States Approval
  18. Supplemental Biologics License Application (sBLA)
  19. Acquisition
  20. Technology
  21. Designation
  22. Agreement
  23. Technology Transfer
  24. Marketed Details
  25. United States
  26. Europe
  27. Cinryze Sales Assessment
  28. Global
  29. Analyst Insights
  30. Patent Details
  31. Global API Manufacturers
  32. India
  33. Market Competitors
  34. Emerging Therapies
  35. SWOT Analysis
  36. Appendix